AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21961467 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood supports for physical activity (parks, lighting)
Number of subjects: 679
Study 19320276 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole capsule
Number of subjects: 24
Study 16982282 — intervention group
Group type: EXPERIMENTAL
Intervention: AH Plus (thick layer)
Number of subjects: 82
Study 16982282 — intervention group
Group type: COMPARATOR
Intervention: Pulp Canal Sealer (thick layer)
Number of subjects: 82
Study 16982282 — intervention group
Group type: COMPARATOR
Intervention: EndoREZ (thick layer)
Number of subjects: 82
Study 16982282 — intervention group
Group type: COMPARATOR
Intervention: Sealapex (thick layer)
Number of subjects: 82
Study 16982282 — intervention group
Group type: COMPARATOR
Intervention: Pulp Canal Sealer (thin layer)
Number of subjects: 82
Study 16982282 — intervention group
Group type: COMPARATOR
Intervention: EndoREZ (thin layer)
Number of subjects: 82
Study 16982282 — intervention group
Group type: COMPARATOR
Intervention: Sealapex (thin layer)
Number of subjects: 82
Study 16982282 — intervention group
Group type: COMPARATOR
Intervention: AH Plus (thin layer)
Number of subjects: 82
Study 15333432 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 60
Study 15333432 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% levobupivacaine
Number of subjects: 60
Study 15333432 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% levobupivacaine
Number of subjects: 60
Study 10952406 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl plaster
Number of subjects: 18
Study 10952406 — intervention group
Group type: COMPARATOR
Intervention: Sustained release morphine tablets
Number of subjects: 18
Study 9400906 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 1533
Study 9400906 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training
Number of subjects: 1533
Study 9400906 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 1533
Study 8298547 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation treatment
Number of subjects: 21
Study 8298547 — intervention group
Group type: COMPARATOR
Intervention: Attention-control
Number of subjects: 21
Study 8298547 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 21
Study 3434765 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichloroethylene
Number of subjects: 40
Study 3434765 — intervention group
Group type: COMPARATOR
Intervention: Enflurane
Number of subjects: 40
Study 3434765 — intervention group
Group type: COMPARATOR
Intervention: Enflurane plus fentanyl
Number of subjects: 40
Study 29175451 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric Pudendal Nerve Stimulation (EPNS)
Number of subjects: 60
Study 27904000 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (6 g/d for 8 weeks)
Number of subjects: 34
Study 27904000 — intervention group
Group type: COMPARATOR
Intervention: Medium chain triglycerides oil (6 g/d for 8 weeks)
Number of subjects: 34
Study 25033743 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling sessions including grandmothers
Number of subjects: 323
Study 25033743 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling sessions excluding grandmothers
Number of subjects: 323
Study 25033743 — intervention group
Group type: COMPARATOR
Intervention: No intervention, living with mother
Number of subjects: 323
Study 25033743 — intervention group
Group type: COMPARATOR
Intervention: No intervention, not living with mother
Number of subjects: 323
Study 22958441 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker (CHW)‐based interpersonal communication campaign (IPC)
Number of subjects: 0
Study 22958441 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 0
Study 19710086 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaloglide
Number of subjects: 45
Study 19710086 — intervention group
Group type: COMPARATOR
Intervention: Standard release (Control)
Number of subjects: 45
Study 18279374 — intervention group
Group type: COMPARATOR
Intervention: BsmI-TaqI BT haplotype
Number of subjects: 145
Study 18279374 — intervention group
Group type: EXPERIMENTAL
Intervention: bT haplotype
Number of subjects: 145
Study 18279374 — intervention group
Group type: EXPERIMENTAL
Intervention: baT haplotype
Number of subjects: 145
Study 18279374 — intervention group
Group type: EXPERIMENTAL
Intervention: BaT haplotype
Number of subjects: 145
Study 18279374 — intervention group
Group type: EXPERIMENTAL
Intervention: rs1544410 polymorphism
Number of subjects: 145
Study 16030275 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid feedback on quality indicators (n = 38 hospitals, 2533 patients)
Number of subjects: 5675
Study 16030275 — intervention group
Group type: COMPARATOR
Intervention: Delayed feedback on quality indicators (n = 38 hospitals, 3142 patients)
Number of subjects: 5675
Study 12603640 — intervention group
Group type: EXPERIMENTAL
Intervention: rizatriptan 10‐mg standard tablets
Number of subjects: 5388
Study 12603640 — intervention group
Group type: EXPERIMENTAL
Intervention: rizatriptan 10‐mg orally disintegrating tablets
Number of subjects: 5388
Study 12603640 — intervention group
Group type: COMPARATOR
Intervention: Oral usual care medications
Number of subjects: 5388
Study 10334901 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial checkerboard stimuli
Number of subjects: 0
Study 10334901 — intervention group
Group type: COMPARATOR
Intervention: Diffuse chromatic stimulus with no luminance variation
Number of subjects: 0
Study 10334901 — intervention group
Group type: COMPARATOR
Intervention: Very high spatial frequency luminance grating
Number of subjects: 0
Study 8697550 — intervention group
Group type: EXPERIMENTAL
Intervention: 2M2V (mivacurium 0.15 mg.kg‐1 plus vecuronium 0.1 mg.kg‐1)
Number of subjects: 30
Study 8697550 — intervention group
Group type: COMPARATOR
Intervention: 2V (2 x ED95 of vecuronium)
Number of subjects: 30
Study 8697550 — intervention group
Group type: EXPERIMENTAL
Intervention: 4V (4 x ED95 of vecuronium)
Number of subjects: 30
Study 1853859 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized dietary advice based on the Netherlands Nutrition Council guidelines
Number of subjects: 80
Study 1853859 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary intervention)
Number of subjects: 80
Study 7049013 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol syrup
Number of subjects: 11
Study 7049013 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline syrup
Number of subjects: 11
Study 7049013 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 11
Study 29551699 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 61
Study 29551699 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES)
Number of subjects: 61
Study 29551699 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IMT + FES
Number of subjects: 61
Study 29551699 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 61
Study 29431251 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399
Study 27089049 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with tegafur–uracil (UFT)
Number of subjects: 304
Study 27089049 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 304
Study 27089049 — intervention group
Group type: EXPERIMENTAL
Intervention: Mismatch repair (MMR) status
Number of subjects: 304
Study 24582719 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (125mg)
Number of subjects: 25
Study 24582719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 24582719 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (125mg) with naloxone (10mg)
Number of subjects: 25
Study 24582719 — intervention group
Group type: COMPARATOR
Intervention: Placebo with naloxone (10mg)
Number of subjects: 25
Study 24582719 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant
Number of subjects: 25
Study 23126348 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational Care (EC)
Number of subjects: 188
Study 23126348 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 188
Study 19887192 — intervention group
Group type: EXPERIMENTAL
Intervention: Open VIH
Number of subjects: 145
Study 19887192 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic VIH
Number of subjects: 145
Study 19887192 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with seromas
Number of subjects: 145
Study 19887192 — intervention group
Group type: COMPARATOR
Intervention: Patients without seromas
Number of subjects: 145
Study 19887192 — intervention group
Group type: EXPERIMENTAL
Intervention: Seromas
Number of subjects: 145
Study 17319428 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine 10 mg + 15 microg fentanyl
Number of subjects: 50
Study 17319428 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine 11 mg + 15 microg fentanyl
Number of subjects: 50
Study 17319428 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine 12 mg + 15 microg fentanyl
Number of subjects: 50
Study 17319428 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine 13 mg + 15 microg fentanyl
Number of subjects: 50
Study 17319428 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine 14 mg (no fentanyl)
Number of subjects: 50
Study 15003297 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided BTX-A injections (Group A, n=8)
Number of subjects: 15
Study 15003297 — intervention group
Group type: COMPARATOR
Intervention: Blind BTX-A injections (Group B, n=7)
Number of subjects: 15
Study 11479250 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 1016
Study 11479250 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1016
Study 9595969 — intervention group
Group type: EXPERIMENTAL
Intervention: African American elders
Number of subjects: 0
Study 9595969 — intervention group
Group type: COMPARATOR
Intervention: Education-matched groups
Number of subjects: 0
Study 8092501 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg/kg
Number of subjects: 97
Study 8092501 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 97
Study 3391621 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30
Study 3391621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3391621 — intervention group
Group type: COMPARATOR
Intervention: Discontinuation of treatment
Number of subjects: 30
Study 27523397 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-knee compression garments
Number of subjects: 44
Study 27523397 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary task
Number of subjects: 44
Study 27519922 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal NOTES
Number of subjects: 0
Study 27519922 — intervention group
Group type: COMPARATOR
Intervention: Classical laparoscopy
Number of subjects: 0
Study 24678906 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin 10 mg
Number of subjects: 230
Study 24678906 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin 20 mg
Number of subjects: 230
Study 24678906 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin 40 mg
Number of subjects: 230
Study 24678906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 24678906 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin (all doses)
Number of subjects: 230
Study 22198969 — intervention group
Group type: EXPERIMENTAL
Intervention: Amygdala reactivity to angry faces
Number of subjects: 0
Study 22198969 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry facial expressions
Number of subjects: 0
Study 21595861 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbal silicone oil removal (n = 8)
Number of subjects: 16
Study 21595861 — intervention group
Group type: COMPARATOR
Intervention: Pars plana silicone oil removal (n = 8)
Number of subjects: 16
Study 21595861 — intervention group
Group type: EXPERIMENTAL
Intervention: Both limbal and pars plana SOR
Number of subjects: 16
Study 21595861 — intervention group
Group type: COMPARATOR
Intervention: Limbal silicone oil removal
Number of subjects: 16
Study 21595861 — intervention group
Group type: COMPARATOR
Intervention: Silicone oil injection
Number of subjects: 16
Study 21595861 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (BSS) injection
Number of subjects: 16
Study 18511439 — intervention group
Group type: EXPERIMENTAL
Intervention: SPV-guided intraoperative fluid management
Number of subjects: 80
Study 18511439 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study 16359587 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic treatment
Number of subjects: 32
Study 16359587 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 32
Study 14671164 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg GH/m(2).d
Number of subjects: 75
Study 14671164 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg GH/m(2).d
Number of subjects: 75
Study 14671164 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 75
Study 14671164 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg GH/m(2).d and 2 mg GH/m(2).d
Number of subjects: 75
Study 10632908 — intervention group
Group type: EXPERIMENTAL
Intervention: Wis‐Hipple laryngoscope (WhL)
Number of subjects: 50
Study 10632908 — intervention group
Group type: COMPARATOR
Intervention: Adult Bullard laryngoscope (BL)
Number of subjects: 50
Study 8693230 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS)
Number of subjects: 90
Study 8693230 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 90
Study 8693230 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 90
Study 8693230 — intervention group
Group type: COMPARATOR
Intervention: Endorectal coil magnetic resonance imaging (EMRI)
Number of subjects: 90
Study 1643677 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (4 ml 0.5% isobaric bupivacaine)
Number of subjects: 65
Study 1643677 — intervention group
Group type: COMPARATOR
Intervention: Epidural anaesthesia (15 ml of 0.5% bupivacaine)
Number of subjects: 65
Study 6375709 — intervention group
Group type: EXPERIMENTAL
Intervention: glaucine 30 mg
Number of subjects: 24
Study 6375709 — intervention group
Group type: EXPERIMENTAL
Intervention: dextromethorphan 30 mg
Number of subjects: 24
Study 6375709 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 30858257 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit Planner (waiting room health IT tool)
Number of subjects: 750
Study 30858257 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 750
Study 28422579 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar disorder
Number of subjects: 0
Study 28422579 — intervention group
Group type: COMPARATOR
Intervention: Major depressive disorder
Number of subjects: 0
Study 28422579 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar disorder during mania
Number of subjects: 0
Study 27238859 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3% liposomal bupivacaine via ultrasound-guided bilateral TAP block
Number of subjects: 60
Study 27238859 — intervention group
Group type: COMPARATOR
Intervention: 0.25% non-liposomal bupivacaine with adrenaline via ultrasound-guided bilateral TAP block
Number of subjects: 60
Study 24504577 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoles used for ulcer prevention
Number of subjects: 60
Study 22924353 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamine silver fluoride/potassium iodide
Number of subjects: 19
Study 22924353 — intervention group
Group type: COMPARATOR
Intervention: Oxalic acid-based preparation
Number of subjects: 19
Study 19904816 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone hydrogel contact lenses
Number of subjects: 7
Study 19904816 — intervention group
Group type: COMPARATOR
Intervention: Conventional hydrogel contact lenses
Number of subjects: 7
Study 18033568 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block (0.50% bupivacaine hydrochloride with epinephrine 1:200,000)
Number of subjects: 42
Study 18033568 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 42
Study 18033568 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 15853164 — intervention group
Group type: EXPERIMENTAL
Intervention: Humor interventions
Number of subjects: 0
Study 12475448 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy
Number of subjects: 2457
Study 12475448 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive strategy
Number of subjects: 2457
Study 9500624 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine microemulsion (CsA‐ME)
Number of subjects: 1097
Study 9500624 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 1097
Study 8539008 — intervention group
Group type: EXPERIMENTAL
Intervention: Objects presented in the same category (sequential and simultaneous trials)
Number of subjects: 4
Study 8539008 — intervention group
Group type: COMPARATOR
Intervention: Objects presented in mixed categories (sequential and simultaneous trials)
Number of subjects: 4
Study 8539008 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous presentation of objects
Number of subjects: 4
Study 8539008 — intervention group
Group type: COMPARATOR
Intervention: Sequential presentation of objects
Number of subjects: 4
Study 2379297 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheum officinale Baill
Number of subjects: 312
Study 2379297 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheum palmatum L
Number of subjects: 312
Study 2379297 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheum tanguticum Maxim ex Balf
Number of subjects: 312
Study 718785 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine analgesia
Number of subjects: 0
Study 718785 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural analgesia
Number of subjects: 0
Study 718785 — intervention group
Group type: EXPERIMENTAL
Intervention: No analgesia
Number of subjects: 0
Study 718785 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine + Extradural analgesia
Number of subjects: 0
Study 718785 — intervention group
Group type: COMPARATOR
Intervention: Elective Caesarean sections
Number of subjects: 0
Study 31784809 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Incision Mini-Sling (SIMS)
Number of subjects: 105
Study 31784809 — intervention group
Group type: COMPARATOR
Intervention: Transobturator Tape (TOT)
Number of subjects: 105
Study 31784809 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 105
Study 29932230 — intervention group
Group type: EXPERIMENTAL
Intervention: 200‐mg selenium yeast tablets
Number of subjects: 145
Study 29932230 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 145
Study 28641972 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterolateral surgical approach
Number of subjects: 49
Study 28641972 — intervention group
Group type: COMPARATOR
Intervention: Posterior surgical approach
Number of subjects: 49
Study 26169592 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient decision aid (P-DA) with usual care
Number of subjects: 0
Study 26169592 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 26169592 — intervention group
Group type: EXPERIMENTAL
Intervention: P-DA
Number of subjects: 0
Study 26169592 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study 23063567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous silibinin (SIL)
Number of subjects: 14
Study 23063567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 20097683 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of mid‐regional pro‐atrial natriuretic peptide (MR‐proANP)
Number of subjects: 1237
Study 20097683 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of mid‐regional pro‐adrenomedullin (MR‐proADM)
Number of subjects: 1237
Study 20097683 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of C‐terminal pro‐endothelin‐1 (CT‐proET‐1)
Number of subjects: 1237
Study 20097683 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of C‐terminal pro‐vasopressin (CT‐proAVP or copeptin)
Number of subjects: 1237
Study 18375894 — intervention group
Group type: EXPERIMENTAL
Intervention: MA 20 mg
Number of subjects: 288
Study 18375894 — intervention group
Group type: EXPERIMENTAL
Intervention: MA 40 mg
Number of subjects: 288
Study 18375894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study 16725260 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 22
Study 16725260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 15055983 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest Night Effects (19% sodium percarbonate)
Number of subjects: 57
Study 15055983 — intervention group
Group type: COMPARATOR
Intervention: Colgate Simply White Night (8.7% hydrogen peroxide)
Number of subjects: 57
Study 10895743 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine
Number of subjects: 802
Study 10895743 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular pethidine (up to 300 mg)
Number of subjects: 802
Study 9073055 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical surgery with pelvic lymphadenectomy (Group A, 72 patients)
Number of subjects: 92
Study 9073055 — intervention group
Group type: COMPARATOR
Intervention: High-voltage external irradiation 40 Gy to a pelvic field (Group B, 70 patients)
Number of subjects: 92
Study 9073055 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative irradiation 40 to 50 Gy (Group A, if lymph node metastases found)
Number of subjects: 92
Study 9073055 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (Group A)
Number of subjects: 92
Study 9073055 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (Group B)
Number of subjects: 92